Nine Square Therapeutics nets $50m Series A
San Francisco-based Nine Square Therapeutics, a developer of new treatments for movement disorders, has raised $50 million in Series A funding.
7 July 2020•1 min read
San Francisco-based Nine Square Therapeutics, a developer of new treatments for movement disorders, has raised $50 million in Series A funding.
